Science Speaks is at IDWeek in San Diego, California this week, bringing live coverage of sessions on HIV, TB, Ebola and more. SAN DIEGO, Calif. – At one of the first sessions of this conference of infectious diseases physicians, scientists discussed an urgent need to scale up tuberculosis prevention efforts globally, especially in light of data expected from the World Health […]
NIH Director Collins, in turn, says 10 percent apportioned to HIV for last two decades won’t be automatic “As a practicing physician, sometimes still,” Sen. William Cassidy (R – La), told National Institutes of Health Director Dr. Francis Collins today during an Appropriations sub-committee hearing on funding for the agency, “I think we should double your […]
HIV
The following is a guest post by Maureen Luba Milambe, African Regional Advocacy Advisor, AVAC On Tuesday (June 8), the UN General Assembly voted overwhelmingly to […]
Tuberculosis
The publication of trial data showing a four-month treatment regimen for tuberculosis that is not resistant to first-line medicines as effective as the currently widely prescribed […]
Research & Development
By Mitchell Warren, executive director, AVAC In February 2020, just as the COVID pandemic began its rapid global spread, a major HIV vaccine trial called HVTN […]
Policy
By Karen Carvajal, M.D. Over the course of human history we have come a long way in our fight against the threat of infectious diseases and, […]